Call for prospective studies of continuous glucose monitoring to define the glycaemic response to bariatric surgery
Lancet Diabetes Endocrinol
.
2023 Oct;11(10):712-714.
doi: 10.1016/S2213-8587(23)00228-0.
Epub 2023 Aug 28.
Authors
Lia Bally
1
,
Bernard Khoo
2
,
Filip Knop
3
,
Sten Madsbad
4
,
Mary-Elizabeth Patti
5
,
Tricia Tan
6
Affiliations
1
Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, University Hospital of Bern, University of Bern, Bern, Switzerland.
2
Endocrinology, Division of Medicine, University College London, London, UK.
3
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
4
Department of Endocrinology, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark.
5
Joslin Diabetes Center, Harvard Medical School, Harvard University, Boston, MA, USA.
6
Department of Metabolism, Digestion and Reproduction, Imperial College London, London W12 0HS, UK. Electronic address: t.tan@imperial.ac.uk.
PMID:
37652072
DOI:
10.1016/S2213-8587(23)00228-0
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Editorial
MeSH terms
Bariatric Surgery*
Blood Glucose Self-Monitoring
Blood Glucose*
Humans
Hypoglycemic Agents
Prospective Studies
Substances
Blood Glucose
Hypoglycemic Agents